key: cord-0800629-jermh1o1 authors: Shirke, Manasi Mahesh; Shaikh, Safwan Ahmed; Harky, Amer title: Tele-oncology in the COVID-19 era: The way forward? date: 2020-05-27 journal: Trends Cancer DOI: 10.1016/j.trecan.2020.05.013 sha: 4ca4cfbea0c187bc45ee1717c357e9a6f5ee3e05 doc_id: 800629 cord_uid: jermh1o1 Abstract COVID-19 has had a devastating impact on the care of cancer patients. Thus, tele-oncology has become a necessity to improve cancer care. Several organizations have issued guidelines for its use during COVID-19. Despite certain shortcomings, tele-oncology has great potential to help cancer patients during COVID-19 and in the future. The Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Virus (SARS-CoV-2) has resulted in a pandemic that has placed immense pressure on health care systems around the world. This has resulted in hospitals sending patients home if they are not acutely unwell and don't require urgent attention, further leading to an increase in patients from specialties like oncology, not being able to attend hospitals for non-urgent care. As a result, tele-oncology has taken a more prominent role in the COVID-19 pandemic. Tele-oncology is defined as the delivery of clinical oncology services via audio and video communication technologies to patients at a distance. It is effective in providing remote chemotherapy supervision, symptom management, and palliative care to cancer patients [1] . Telemedicine and its applications in different specialties such as cardiology, respiratory medicine, and neurology has been extensively researched and they reported satisfactory outcomes [2] . However, its use in oncology and in particular during COVID-19 has not garnered the same attention. J o u r n a l P r e -p r o o f A growing trend of telemedicine in oncology is observed with a call for outpatient visits and triage to be shifted to phone consultations incorporating a risk-benefit balance. This reduces the risk of contagion for the health personnel and patients especially when the potential benefit of an oncological intervention in terms of cancer recurrence/overall survival is so small that it doesn't counterbalance the potential risk It is well established that comorbidities and immunosuppression are common risk factors for severity and mortality. As cancer and cancer treatment frequently cause immunosuppression, they increase the susceptibility to contracting the virus. In addition, hyperinflammatory response to the infection may be responsible for organ damage associated with severe COVID-19 in the immunocompromised [4] . Therefore, major shifts in the clinical care of cancer are currently underway with more light being shed on tele-oncology. Several organizations have endorsed the use of tele-oncology and issued guidelines for its use during COVID-19. The European Society for Medical Oncology (ESMO) recommends that patients undertaking oral treatments should be transferred to telephonic consultation and web-technology contacts for a prescription renewal. ESMO also endorses the use of telephone and web-technology for toxicity evaluation, dose adaptation and supportive care recommendation [5] . The tiered approach of ESMO advises that low and medium priority cancer patients be referred to tele-oncology services as much as possible. J o u r n a l P r e -p r o o f 5 The National Health Service (NHS) England has issued guidance to support the use of telephone or video consultation wherever possible to minimize face-to-face appointments [3] . Additionally, that if staff have to self-isolate for any reason, they could still continue to provide care and support multidisciplinary teams (MDTs) through video consultations and virtual attendance at MDT meetings [1] . Many different types of technologies have been adopted by tele-oncology to further the health of cancer patients. These include web conferencing, videoconferencing, tele-synergy and virtual tele-microscope. The advantages and disadvantages of the various technologies are summarised in Table 1 [6] . Analyzing 200 patient interactions, Lewis et al. proved that a great patient satisfaction is associated with the radiation oncology services provided virtually. Hence, concluding that tele-oncology is an efficient and cost-effective method of providing high-quality services for the long-term follow-up of cancer patients [7] . Tele-oncology can also be useful to triage for COVID-19. A video-based consultation would enable clinicians to establish a history of symptoms, exposure risk and observational assessment. This would aid the clinicians in making the decision to test a particular individual for COVID-19 [8] . Cancer Patient Care during COVID-19. Cancer Cell Interactive telemedicine: effects on professional practice and health care outcomes Clinical guide for the management of noncoronavirus patients requiring acute treatment: cancer COVID-19 and Multi-Organ Response Cancer Patient Management During the COVID-19 Pandemic Teleoncology: current and future applications for improving cancer care globally Long-term Institutional Experience with Telemedicine Services for Radiation Oncology: A Potential Model for Long-term Utilization Telemedicine in the Era of COVID-19. The journal of allergy and clinical immunology How effective is video consultation in clinical oncology? A systematic review COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities Population-Level Interest and Telehealth Capacity of US Hospitals in Response to COVID-19: Cross-Sectional Analysis of Google Search and National Hospital Survey Data. JMIR public health and surveillance Managing Cancer Care during the COVID-19